Cargando…
Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease
Idiopathic Parkinson’s disease (iPD) is characterized by degeneration of the dopaminergic substantia nigra pars compacta (SNc), typically in the presence of Lewy pathology (LP) and mitochondrial respiratory complex I (CI) deficiency. LP is driven by α-synuclein aggregation, morphologically evolving...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220830/ https://www.ncbi.nlm.nih.gov/pubmed/35740871 http://dx.doi.org/10.3390/biom12060747 |
_version_ | 1784732467171688448 |
---|---|
author | Flønes, Irene Hana Nyland, Harald Sandnes, Dagny-Ann Alves, Guido Werner Tysnes, Ole-Bjørn Tzoulis, Charalampos |
author_facet | Flønes, Irene Hana Nyland, Harald Sandnes, Dagny-Ann Alves, Guido Werner Tysnes, Ole-Bjørn Tzoulis, Charalampos |
author_sort | Flønes, Irene Hana |
collection | PubMed |
description | Idiopathic Parkinson’s disease (iPD) is characterized by degeneration of the dopaminergic substantia nigra pars compacta (SNc), typically in the presence of Lewy pathology (LP) and mitochondrial respiratory complex I (CI) deficiency. LP is driven by α-synuclein aggregation, morphologically evolving from early punctate inclusions to Lewy bodies (LBs). The relationship between α-synuclein aggregation and CI deficiency in iPD is poorly understood. While studies in models suggest they are causally linked, observations in human SNc show that LBs preferentially occur in CI intact neurons. Since LBs are end-results of α-synuclein aggregation, we hypothesized that the relationship between LP and CI deficiency may be better reflected in neurons with early-stage α-synuclein pathology. Using quadruple immunofluorescence in SNc tissue from eight iPD subjects, we assessed the relationship between neuronal CI or CIV deficiency and early or late forms of LP. In agreement with previous findings, we did not observe CI-negative neurons with late LP. In contrast, early LP showed a significant predilection for CI-negative neurons (p = 6.3 × 10(−5)). CIV deficiency was not associated with LP. Our findings indicate that early α-syn aggregation is associated with CI deficiency in iPD, and suggest a double-hit mechanism, where neurons exhibiting both these pathologies are selectively lost. |
format | Online Article Text |
id | pubmed-9220830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92208302022-06-24 Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease Flønes, Irene Hana Nyland, Harald Sandnes, Dagny-Ann Alves, Guido Werner Tysnes, Ole-Bjørn Tzoulis, Charalampos Biomolecules Article Idiopathic Parkinson’s disease (iPD) is characterized by degeneration of the dopaminergic substantia nigra pars compacta (SNc), typically in the presence of Lewy pathology (LP) and mitochondrial respiratory complex I (CI) deficiency. LP is driven by α-synuclein aggregation, morphologically evolving from early punctate inclusions to Lewy bodies (LBs). The relationship between α-synuclein aggregation and CI deficiency in iPD is poorly understood. While studies in models suggest they are causally linked, observations in human SNc show that LBs preferentially occur in CI intact neurons. Since LBs are end-results of α-synuclein aggregation, we hypothesized that the relationship between LP and CI deficiency may be better reflected in neurons with early-stage α-synuclein pathology. Using quadruple immunofluorescence in SNc tissue from eight iPD subjects, we assessed the relationship between neuronal CI or CIV deficiency and early or late forms of LP. In agreement with previous findings, we did not observe CI-negative neurons with late LP. In contrast, early LP showed a significant predilection for CI-negative neurons (p = 6.3 × 10(−5)). CIV deficiency was not associated with LP. Our findings indicate that early α-syn aggregation is associated with CI deficiency in iPD, and suggest a double-hit mechanism, where neurons exhibiting both these pathologies are selectively lost. MDPI 2022-05-25 /pmc/articles/PMC9220830/ /pubmed/35740871 http://dx.doi.org/10.3390/biom12060747 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Flønes, Irene Hana Nyland, Harald Sandnes, Dagny-Ann Alves, Guido Werner Tysnes, Ole-Bjørn Tzoulis, Charalampos Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease |
title | Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease |
title_full | Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease |
title_fullStr | Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease |
title_full_unstemmed | Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease |
title_short | Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease |
title_sort | early forms of α-synuclein pathology are associated with neuronal complex i deficiency in the substantia nigra of individuals with parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220830/ https://www.ncbi.nlm.nih.gov/pubmed/35740871 http://dx.doi.org/10.3390/biom12060747 |
work_keys_str_mv | AT flønesirenehana earlyformsofasynucleinpathologyareassociatedwithneuronalcomplexideficiencyinthesubstantianigraofindividualswithparkinsonsdisease AT nylandharald earlyformsofasynucleinpathologyareassociatedwithneuronalcomplexideficiencyinthesubstantianigraofindividualswithparkinsonsdisease AT sandnesdagnyann earlyformsofasynucleinpathologyareassociatedwithneuronalcomplexideficiencyinthesubstantianigraofindividualswithparkinsonsdisease AT alvesguidowerner earlyformsofasynucleinpathologyareassociatedwithneuronalcomplexideficiencyinthesubstantianigraofindividualswithparkinsonsdisease AT tysnesolebjørn earlyformsofasynucleinpathologyareassociatedwithneuronalcomplexideficiencyinthesubstantianigraofindividualswithparkinsonsdisease AT tzoulischaralampos earlyformsofasynucleinpathologyareassociatedwithneuronalcomplexideficiencyinthesubstantianigraofindividualswithparkinsonsdisease |